Moors & Cabot’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
CS
FCM
LP
Moors & Cabot's AGN Position: Q4 2019 in Review
Moors & Cabot sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 1,788 shares — an estimated $300K sold.
Moors & Cabot first reported a position in AGN in Q1 2015 and held it in 19 quarters. The position peaked at $2.48M in Q3 2017. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.
- Moors & Cabot reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
- Moors & Cabot sold 1,788 Allergan plc shares in Q4 2019, an estimated $300K.
- Moors & Cabot first reported a position in Allergan plc in Q1 2015 and held it in 19 quarters.
- Moors & Cabot's Allergan plc position peaked at $2.48M in Q3 2017.
- 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.
Based on Moors & Cabot's 13F filing for Q4 2019, filed 28 Jan 2020.